Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer

Progress in the treatment options for small cell lung cancer (SCLC) remains poor. Concerns exist regarding the efficacy of bevacizumab in SCLC. The present study aimed to evaluate the efficacy of bevacizumab in extensive stage (ES)-SCLC. A meta-analysis on studies conducted and listed on the Medline...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yan-Juan, Zhang, Hai-Bo, Liu, Yi-Hong, Bai, Jian-Ping, Li, Yong, Liu, Li-Rong, Qu, Yan-Chun, Qu, Xin, Chen, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494762/
https://www.ncbi.nlm.nih.gov/pubmed/28693218
http://dx.doi.org/10.3892/ol.2017.6249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494762/
https://www.ncbi.nlm.nih.gov/pubmed/28693218
http://dx.doi.org/10.3892/ol.2017.6249

Ejemplares similares